(VIANEWS) – Viper Energy Partners LP (VNOM), Devon Energy (DVN), West Pharmaceutical (WST) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Viper Energy Partners LP (VNOM)

72.5% sales growth and 17.63% return on equity

Viper Energy Partners LP acquires and owns natural gas properties throughout North America.

Viper Energy Partners LP’s sales growth this year is anticipated to be 65.1% and a negative 5.3% for next year.

Year-on-year quarterly revenue growth grew by 108.6%, now sitting on 578.22M for the twelve trailing months.

Volume

Today’s last reported volume for Viper Energy Partners LP is 405896 which is 33.37% below its average volume of 609241.

Viper Energy Partners LP’s sales growth for the next quarter is 72.5%. The company’s growth estimates for the present quarter and the next is 611.1% and 190.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.63%.

Volatility

Viper Energy Partners LP’s last day, last week, and last month’s current intraday variation average was 3.61%, 2.77%, and 3.01%, respectively.

Viper Energy Partners LP’s highest amplitude of average volatility was 3.20% (day), 4.05% (last week), and 4.55% (last month), respectively.

Viper Energy Partners LP’s Stock Yearly Top and Bottom Value

Viper Energy Partners LP’s stock is valued at $29.65 at 06:23 EST, way under its 52-week high of $35.85 and way above its 52-week low of $16.49.

Viper Energy Partners LP’s Moving Average

Viper Energy Partners LP’s value is above its 50-day moving average of $29.22 and way above its 200-day moving average of $26.92.

2. Devon Energy (DVN)

40.3% sales growth and 40.31% return on equity

Devon Energy Corporation is an independent energy company that primarily deals in exploration, development and production of natural gas and natural gas liquids within the United States.

Devon Energy’s sales growth this year is anticipated to be 50.3% and 1.2% for next year.

Year-on-year quarterly revenue growth grew by 74%, now sitting on 14.94B for the twelve trailing months.

Volume

Today’s last reported volume for Devon Energy is 12839900 which is 3.05% above its average volume of 12459900.

Devon Energy’s sales growth for the next quarter is 40.3%. The company’s growth estimates for the present quarter and the next is 296.7% and 126.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 40.31%.

Volatility

Devon Energy’s last day, last week, and last month’s current intraday variation average was 7.34%, 3.53%, and 3.25%, respectively.

Devon Energy’s highest amplitude of average volatility was 5.05% (day), 4.71% (last week), and 4.65% (last month), respectively.

Devon Energy’s Stock Yearly Top and Bottom Value

Devon Energy’s stock is valued at $64.59 at 06:23 EST, way under its 52-week high of $79.40 and way above its 52-week low of $24.46.

Devon Energy’s Moving Average

Devon Energy’s worth is higher than its 50-day moving average of $61.84 and way higher than its 200-day moving average of $54.76.

3. West Pharmaceutical (WST)

21.2% sales growth and 28.54% return on equity

West Pharmaceutical Services, Inc. produces and sells systems that contain and deliver injectable medicines and other healthcare products throughout the United States, Germany, Ireland, France, Ireland, France, Spain, Italy, Germany, France, Germany, Ireland, France, The United Kingdom, as well as internationally.

West Pharmaceutical’s sales growth this year is anticipated to be 30.4% and 8% for next year.

Year-on-year quarterly revenue growth grew by 37.3%, now sitting on 2.52B for the twelve trailing months.

Volume

Today’s last reported volume for West Pharmaceutical is 178730 which is 57.53% below its average volume of 420877.

West Pharmaceutical’s sales growth for the next quarter is 21.2%. The company’s growth estimates for the ongoing quarter and the next is 56.5% and 41.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.54%.

Volatility

West Pharmaceutical’s last day, last week, and last month’s current intraday variation average was 0.32%, 1.33%, and 1.23%, respectively.

West Pharmaceutical’s highest amplitude of average volatility was 2.83% (day), 2.34% (last week), and 2.20% (last month), respectively.

West Pharmaceutical’s Stock Yearly Top and Bottom Value

West Pharmaceutical’s stock is valued at $337.83 at 06:23 EST, way below its 52-week high of $475.35 and way higher than its 52-week low of $253.85.

West Pharmaceutical’s Moving Average

West Pharmaceutical’s worth is way under its 50-day moving average of $424.37 and way below its 200-day moving average of $379.25.

4. Camtek Ltd. (CAMT)

13.2% sales growth and 23.14% return on equity

Camtek Ltd. and its subsidiaries develop, manufacture, and sell inspection and metrology equipment. They do this for advanced interconnect packaging and memory.

Camtek Ltd.’s sales growth this year is anticipated to be 17.2% and 8.2% for next year.

Year-on-year quarterly revenue growth grew by 52.6%, now sitting on 269.66M for the twelve trailing months.

Volume

Today’s last reported volume for Camtek Ltd. is 173023 which is 13.19% above its average volume of 152859.

Camtek Ltd.’s sales growth for the next quarter is 13.2%. The company’s growth estimates for the current quarter and the next is 15.8% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.14%.

Volatility

Camtek Ltd.’s last day, last week, and last month’s current intraday variation average was 2.49%, 2.38%, and 2.55%, respectively.

Camtek Ltd.’s highest amplitude of average volatility was 4.11% (day), 3.99% (last week), and 4.30% (last month), respectively.

Camtek Ltd.’s Stock Yearly Top and Bottom Value

Camtek Ltd.’s stock is valued at $29.21 at 06:23 EST, way under its 52-week high of $49.60 and way higher than its 52-week low of $22.89.

Camtek Ltd.’s Moving Average

Camtek Ltd.’s value is above its 50-day moving average of $26.89 and way under its 200-day moving average of $34.68.

5. ICF International (ICFI)

11.9% sales growth and 9.09% return on equity

ICF International, Inc. offers management, marketing, technology, policy and consulting services for government clients and international commercial clients.

ICF International’s sales growth this year is expected to be 11.6% and 8.4% for next year.

Year-on-year quarterly revenue growth grew by 9.2%, now sitting on 1.59B for the twelve trailing months.

Volume

Today’s last reported volume for ICF International is 92093 which is 5.85% below its average volume of 97818.

ICF International’s sales growth is a negative 0% for the ongoing quarter and 11.9% for the next. The company’s growth estimates for the current quarter and the next is 10.1% and 3.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.09%.

Volatility

ICF International’s last day, last week, and last month’s current intraday variation average was 1.41%, 1.09%, and 0.93%, respectively.

ICF International’s highest amplitude of average volatility was 2.46% (day), 2.63% (last week), and 2.43% (last month), respectively.

ICF International’s Stock Yearly Top and Bottom Value

ICF International’s stock is valued at $94.35 at 06:23 EST, way under its 52-week high of $108.23 and way higher than its 52-week low of $84.68.

ICF International’s Moving Average

ICF International’s worth is under its 50-day moving average of $94.98 and below its 200-day moving average of $96.94.

6. Tennant (TNC)

11.3% sales growth and 11.53% return on equity

Tennant Company manufactures and markets floor-cleaning equipment throughout the Americas and Europe.

Tennant’s sales growth this year is expected to be 5.1% and 2.9% for next year.

Year-on-year quarterly revenue growth declined by 2%, now sitting on 1.09B for the twelve trailing months.

Volume

Today’s last reported volume for Tennant is 22005 which is 56.91% below its average volume of 51079.

Tennant’s sales growth for the next quarter is 11.3%. The company’s growth estimates for the ongoing quarter and the next is a negative 27.1% and negative -3.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.53%.

Volatility

Tennant’s last day, last week, and last month’s current intraday variation average was 1.30%, 1.51%, and 1.04%, respectively.

Tennant’s highest amplitude of average volatility was 2.01% (day), 3.04% (last week), and 2.59% (last month), respectively.

Tennant’s Stock Yearly Top and Bottom Value

Tennant’s stock is valued at $68.59 at 06:23 EST, way below its 52-week high of $85.33 and way above its 52-week low of $54.90.

Tennant’s Moving Average

Tennant’s worth is way above its 50-day moving average of $62.08 and below its 200-day moving average of $74.52.

7. USD Partners LP (USDP)

9.8% sales growth and 126.46% return on equity

USD Partners LP develops and acquires midstream infrastructure assets, logistics solutions, for crude oil and biofuels in the United States.

USD Partners LP’s sales growth this year is expected to be 11.8% and 22.5% for next year.

Year-on-year quarterly revenue growth declined by 1.3%, now sitting on 121.04M for the twelve trailing months.

Volume

Today’s last reported volume for USD Partners LP is 19858 which is 70.92% below its average volume of 68306.

USD Partners LP’s sales growth is a negative 0% for the current quarter and 9.8% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 0% and 15.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 126.46%.

Volatility

USD Partners LP’s last day, last week, and last month’s current intraday variation average was 1.30%, 1.99%, and 1.81%, respectively.

USD Partners LP’s highest amplitude of average volatility was 1.48% (day), 2.80% (last week), and 3.43% (last month), respectively.

USD Partners LP’s Stock Yearly Top and Bottom Value

USD Partners LP’s stock is valued at $5.36 at 06:23 EST, way below its 52-week high of $7.03 and way above its 52-week low of $4.75.

USD Partners LP’s Moving Average

USD Partners LP’s worth is under its 50-day moving average of $5.60 and under its 200-day moving average of $5.79.

LEAVE A REPLY

Please enter your comment!
Please enter your name here